WallStreetZenWallStreetZen

NASDAQ: HYPR
Hyperfine Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Be the first to know when Wall Street analysts revise their HYPR stock forecasts and price targets.

Forecast return on equity

Is HYPR forecast to generate an efficient return?

Company
-65.04%
Industry
20.79%
Market
247.92%
HYPR's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is HYPR forecast to generate an efficient return on assets?

Company
-54.67%
Industry
10.71%
HYPR is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

HYPR earnings per share forecast

What is HYPR's earnings per share in the next 2 years based on estimates from 1 analyst?

Avg 1 year Forecast
-$0.53
Avg 2 year Forecast
-$0.52

HYPR revenue forecast

What is HYPR's revenue in the next 2 years based on estimates from 1 analyst?

Avg 1 year Forecast
$19.3M+45.3%
Avg 2 year Forecast
$24.7M+86.12%
HYPR's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

HYPR revenue growth forecast

How is HYPR forecast to perform vs Medical Devices companies and vs the US market?

Company
45.3%
Industry
10.48%
Market
19.14%
HYPR's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
HYPR's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

HYPR vs Medical Device Stocks

TickerPricePrice TargetUp/downsideConsensus
HYPR$0.93N/AN/A
ICCM$1.18$2.50+111.86%Buy
NSPR$2.76$4.75+72.10%Strong Buy
ICAD$2.41N/AN/A
NVNO$3.52N/AN/A
View Top Medical Device Stocks

Hyperfine Stock Forecast FAQ

What is HYPR's earnings growth forecast for 2025-2026?

(NASDAQ: HYPR) Hyperfine's forecast annual earnings growth rate of N/A is not forecast to beat the US Medical Devices industry's average forecast earnings growth rate of 67.04%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 59.09%.

Hyperfine's earnings in 2025 is -$41,014,000.On average, 1 Wall Street analyst forecast HYPR's earnings for 2025 to be -$38,662,835, with the lowest HYPR earnings forecast at -$38,662,835, and the highest HYPR earnings forecast at -$38,662,835.

In 2026, HYPR is forecast to generate -$37,933,348 in earnings, with the lowest earnings forecast at -$37,933,348 and the highest earnings forecast at -$37,933,348.

If you're new to stock investing, here's how to buy Hyperfine stock.

What is HYPR's revenue growth forecast for 2025-2026?

(NASDAQ: HYPR) Hyperfine's forecast annual revenue growth rate of 45.3% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 10.48%, and it is also forecast to beat the US market's average forecast revenue growth rate of 19.14%.

Hyperfine's revenue in 2025 is $13,255,000.On average, 1 Wall Street analysts forecast HYPR's revenue for 2025 to be $1,404,992,848, with the lowest HYPR revenue forecast at $1,404,992,848, and the highest HYPR revenue forecast at $1,404,992,848.

In 2026, HYPR is forecast to generate $1,799,645,564 in revenue, with the lowest revenue forecast at $1,799,645,564 and the highest revenue forecast at $1,799,645,564.

What is HYPR's forecast return on assets (ROA) for 2025-2026?

(NASDAQ: HYPR) forecast ROA is -54.67%, which is lower than the forecast US Medical Devices industry average of 10.71%.

What is HYPR's Earnings Per Share (EPS) forecast for 2025-2026?

(NASDAQ: HYPR) Hyperfine's current Earnings Per Share (EPS) is -$0.57. On average, analysts forecast that HYPR's EPS will be -$0.53 for 2025, with the lowest EPS forecast at -$0.53, and the highest EPS forecast at -$0.53. In 2026, HYPR's EPS is forecast to hit -$0.52 (min: -$0.52, max: -$0.52).

What is HYPR's forecast return on equity (ROE) for 2025-2026?

(NASDAQ: HYPR) forecast ROE is -65.04%, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.